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required margins. Lorca Marin thermoplastics masks show 
enough accuracy and stability during complete course of 
treatment with intensity modulated techniques in head and 
neck cancer patients. 
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Purpose or Objective: Computed tomography (CT) has 
become an indispensable tool in oncological imaging. Ionising 
radiation is cumulative and carries a stochastic risk of 
malignancy. The implementation of dose reference levels 
(DRLs) for imaging procedures using ionising radiation is 
mandated by European Commission directive 97/43 
EURATOM. There are currently no dose guidelines for 
radiation therapy CT of the head and neck (H&N) region. The 
propose of this research is to establish if variation exists in 
dose delivered by Irish centres; establish a national DRL for 
H&N CT scanning in radiation therapy and compare the 
national DRL with a European sample. 
 
Material and Methods: All radiation therapy centres in 
Ireland and a selection of European centres were invited to 
complete a dose audit survey for 10 average-sized H&N 
patients undergoing a CT localisation scan. Data on CTDIvol, 
DLP, mAs, tube voltage, number of scan phases and scan 
length was collected. 
 
Results: Surveys were returned by five Irish centres, 
representing a 42% response rate and one European centre. 
Significant variation was found in the mean DLP, CTDIvol and 
scan lengths. Based on the rounded 75th percentile of the 
mean DLP and CTDIvol, the proposed Irish DRL is 1025.41mGy 
cm and 20.97mGy, respectively. Based on the European 
survey the DRLs for DLP and CTDIvol were 680.12mGy cm and 
21.85mGy, respectively. 
 
Conclusion: Variation exists in dose used for H&N CT in 
radiation therapy. DRLs have been proposed with the aim of 
dose optimisation for this procedure. 
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Purpose or Objective: The aim of the study was to analyze 
the impact of radiation therapy (RT) or concomitant 
radiochemotherapy (RT-CT) on locoregional control (LRC) in 
patients affected by oral cancer.  
 
Material and Methods: Materials and methods : In this study 
were enrolled 48 patients with oral cancer diagnoses 
underwent postoperative RT or exclusive RT-CT treatment. 
The RT was performed with intensity-modulated radiotherapy 
(IMRT) technique and LINAC DHX of Varian System. All 
patients were treated at the department of Radiotherapy, 
University of Pisa. In patients non treated surgically or 
operated with major risk factors (positive margins, 
Extracapsular extension) RT treatment was performed in 
combination with chemotherapy (CT) or molecular-target 
therapy. Again patients operated with presence of minor risk 
factors (positive lymph nodes, lymphatic vascular invasion, 
perineural invasion) underwent only RT treatment. The 
volumes were defined as follows: PTV high risk: 66Gy (2.2Gy 
/fraction) or 63Gy (2.1Gy / fraction) respectively for 
exclusive RTCT treatment and adjuvant RTCT or RT 
treatment PTV intermediate risk: 60 Gy (2.0Gy /fraction) PTV 
low risk: 54Gy (1.8Gy /fraction)  
 
Results: From January 2011 to July 2015, 48 patients (mean 
age 60.9 years; range 33-87) with histologically confirmed 
diagnosis of oral cancer were treated. At analysis 30 patients 
(62.5%) underwent surgically treatment and 18 (37.5 %) 
performed exclusive RTCT treatment. Twentyfour patients 
were treated with radiochemotherapy or radiotherapy plus 
molecular-target therapy; in 20 patients (83%) was 
administered CDDP; in 4 patients (17%) in combination with 
RT was administered Erbitux. Relapses were divided into 
local (on T), regional (on N) and locoregional (if the 
recurrences were on T and N) and classified, after the merger 
of radiological imaging with radiation therapy planning; in "in 
field" (within the PTV high risk) and “out field" (without PTV 
high risk) After a median follow-up of 19.8 months (range 3-
62 months), six patients (12.5%) developed local recurrence 
"in field" and two patients (4.2%) reported locoregional 
relapse on field. There were not "out field" recurrences. Of 
six patients relapsed 2 (33.3%) underwent salvage surgery and 
subsequent CT; 3 (33.3%) underwent second line CT according 
to Extreme schedule and 1 patient (2%) didn’t any systemic 
treatment but only support care due to comorbidities and 
scarce performance status. At the date of abstract 
submission 3/6 patients died while the others are still alive; 
overall 5/48 patients (10.4 %) died and only 2 died for 
cancer-related causes and three for comorbidities.  
 
Conclusion: The results of our study confirm the data 
reported in literature regarding the locoregional recurrences 
of oral cancer treated with radiotherapy. In field locoregional 
relapse seems to be the main cause of IMRT treatment failure 
regardless the patient underwent at surgery treatment or 
not. 
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Purpose or Objective: Bladder preparatory protocols are 
used in prostate cancer (PCa) radiotherapy (RT) prior to 
simulation (Sim) imaging, and thereafter prior to each 
fraction of RT. Patients are asked to drink, and hold without 
voiding, a constant volume of water. Distension of the 
bladder reduces the volume of the bladder irradiated to high 
doses. A study of online image-guided radiotherapy (IGRT) in 
bladder cancer showed that inter- and intra-fraction 
reproducibility was mostly insensitive to degree of bladder 
filling. Radiographer students were asked to test the 
analogous hypothesis for inter-fraction reproducibility in 
bladder volume over 7 weeks of PCa IGRT. 
 
Material and Methods: An audit of PCa IGRT found 96 cases 
within 1 year of study commencement. 56/96 were locally 
advanced PCa homogeneously treated with bladder 
preparation instructions, daily online cone-beam CT (CBCT) 
verification and 28Gy sequential boost to gland only following 
50Gy to gland plus seminal vesicles by normo-fractionated 
IMRT. 42 were complete cases in which bladders had been 
consistently outlined at Sim and 7 CBCTs weekly. 30/42 men 
agreed to hold 300mL of water each session, but in practice 
only 26/42 were able to comply throughout treatment. 12/42 
men declined the drinking instructions outright. 
 
